You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 169 No. 4, February 23, 2009 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Original Investigation
 •Online Features
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (27)
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Cardiovascular System
 •Prognosis/ Outcomes
 •Cardiovascular Disease/ Myocardial Infarction
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Understanding Physicians' Risk Stratification of Acute Coronary Syndromes

Insights From the Canadian ACS 2 Registry

Andrew T. Yan, MD; Raymond T. Yan, MD; Thao Huynh, MD, MSc; Amparo Casanova, MD, PhD; F. Emilio Raimondo, MD; David H. Fitchett, MD; Anatoly Langer, MD, MSc; Shaun G. Goodman, MD, MSc; for the Canadian Acute Coronary Syndrome Registry 2 Investigators

Arch Intern Med. 2009;169(4):372-378.

Background  An important treatment-risk paradox exists in the management of acute coronary syndromes (ACSs). However, the process of risk stratification by physicians and its relationship to the management of ACS have not been well studied. Our objective was to examine patient risk assessment by physicians in relation to treatment and objective risk score evaluation and the underlying patient characteristics that physicians consider to indicate high risk.

Methods  The prospective Canadian ACS 2 Registry recruited 1956 patients admitted for non-ST-segment elevation ACS in 36 hospitals in October 2002 to December 2003. We recorded patient risk assessment by the treating physician and case management on standardized case report forms and calculated the Thrombolysis in Myocardial Infarction (TIMI), Platelet glycoprotein IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy (PURSUIT), and Global Registry of Acute Cardiac Events (GRACE) risk scores.

Results  Of the 1956 patients with ACS, 347 (17.8%) were classified as low risk, 822 (42.0%) as intermediate risk, and 787 (40.2%) as high risk by their treating physicians. Patients considered as high risk were more likely to receive aggressive medical therapies and to undergo coronary angiography and revascularization. However, there were only weak correlations between risk assessment by physicians and all 3 validated risk scores. In multivariable analysis, history of stroke, worse Killip class, presence of ST-segment deviation, T-wave inversion, and positive cardiac biomarker status were all independently associated with high-risk categorization by the treating physician, while advanced age and previous coronary bypass surgery were independent negative predictors. There was no significant association between the high-risk category and several established prognosticators, such as history of heart failure, hemodynamic variables, and creatinine level.

Conclusions  Contemporary risk stratification of ACS appears suboptimal and may perpetuate the treatment-risk paradox. Physicians may not recognize and incorporate the most powerful adverse prognosticators into overall patient risk assessment. Routine use of validated risk score may enhance risk stratification and facilitate more appropriate tailoring of intensive therapies toward high-risk patients.


Author Affiliations: Terrence Donnelly Heart Centre, Division of Cardiology, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada (Drs A. T. Yan, R. T. Yan, Fitchett, Langer, and Goodman); Canadian Heart Research Centre, Toronto (Drs A. T. Yan, R. T. Yan, Casanova, Fitchett, Langer and Goodman); Division of Cardiology, McGill University Health Centre, McGill University, Montreal, Quebec, Canada (Dr Huynh); Niagara Health System, St Catherines, Ontario (Dr Raimondo).
Group Information: A list of participating Canadian ACS Registry 2 Investigators and Coordinators was published in Arch Intern Med. 2007;167(10):1009-1016.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTER

Is Concentration on More Intensive Treatment for Younger Patients More Rational and Humane Than Ignorant?
Michael Jelinek
Arch Intern Med. 2009;169(15):1442.
EXTRACT | FULL TEXT  

RELATED ARTICLE

In This Issue of Archives of Internal Medicine
Arch Intern Med. 2009;169(4):332.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Adjustment of the GRACE score by growth differentiation factor 15 enables a more accurate appreciation of risk in non-ST-elevation acute coronary syndrome
Widera et al.
Eur Heart J 2011;0:ehr444v1-ehr444.
ABSTRACT | FULL TEXT  

Almanac 2011: acute coronary syndromes. The national society journals present selected research that has driven recent advances in clinical cardiology
Knight and Timmis
Heart 2011;97:1820-1827.
FULL TEXT  

The End of the Risk-Treatment Paradox?: A Rising Tide Lifts All Boats
McAlister
J Am Coll Cardiol 2011;58:1766-1767.
FULL TEXT  

Geriatric Assessment to Improve Risk Stratification in Older Patients Undergoing Coronary Revascularization
Chaudhry and Gill
Circ Cardiovasc Qual Outcomes 2011;4:491-492.
FULL TEXT  

Relationship between risk stratification at admission and treatment effects of early invasive management following fibrinolysis: insights from the Trial of Routine ANgioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI)
Yan et al.
Eur Heart J 2011;32:1994-2002.
ABSTRACT | FULL TEXT  

Cardiovascular Risk Prediction in Patients With Stable and Unstable Coronary Heart Disease
Morrow
Circulation 2010;121:2681-2691.
FULL TEXT  

Association Between Use of Bleeding Avoidance Strategies and Risk of Periprocedural Bleeding Among Patients Undergoing Percutaneous Coronary Intervention
Marso et al.
JAMA 2010;303:2156-2164.
ABSTRACT | FULL TEXT  

Why We Do What We Do?: Making Sense of Antithrombotic Therapy in Patients With Non-ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention
Brener
J Am Coll Cardiol Intv 2010;3:678-679.
FULL TEXT  

Treatment and Risk in Heart Failure: Gaps in Evidence or Quality?
Peterson et al.
Circ Cardiovasc Qual Outcomes 2010;3:309-315.
ABSTRACT | FULL TEXT  

Acute Coronary Syndrome: Emerging Tools for Diagnosis and Risk Assessment
Scirica
J Am Coll Cardiol 2010;55:1403-1415.
ABSTRACT | FULL TEXT  

C-reactive protein improves risk prediction in patients with acute coronary syndrome, or does it?
Kaski
Eur Heart J 2010;31:274-277.
FULL TEXT  

Is Concentration on More Intensive Treatment for Younger Patients More Rational and Humane Than Ignorant?
Jelinek
Arch Intern Med 2009;169:1442-1442.
FULL TEXT  

Is Concentration on More Intensive Treatment for Younger Patients More Rational and Humane Than Ignorant?--Reply
Yan et al.
Arch Intern Med 2009;169:1442-1443.
FULL TEXT  

Risk Stratification in Acute Coronary Syndromes
Journal Watch Cardiology 2009;2009:2-2.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.